These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 15779642)
1. The effectiveness of a hyperoxygenated fatty acid compound in preventing pressure ulcers. Torra i Bou JE; Segovia Gómez T; Verdú Soriano J; Nolasco Bonmatí A; Rueda López J; Arboix i Perejamo M J Wound Care; 2005 Mar; 14(3):117-21. PubMed ID: 15779642 [TBL] [Abstract][Full Text] [Related]
2. [Comparative study of the effectiveness two of hyperoxygenated fatty acids in the treatment of grade I ulcers in geriatric hospitalized patients]. Candela-Zamora MD; Martín-Gómez MA; Solas-Gómez B; Fernández-Pérez C; Martín-González M; Manzanedo-Basilio L; Navarro-Gorjón S; González-Dugo R; Rodríguez-Sánchez S; Nuñez-Marugan MS; Nosti del Valle C; García-Aceña T; Cano-Escudero S; del Prado-González N Enferm Clin; 2010; 20(1):10-6. PubMed ID: 20117031 [TBL] [Abstract][Full Text] [Related]
3. [Mepentol, the first product for the prevention and treatment of grade I pressure ulcers]. Rev Enferm; 2002 Oct; 25(10):41. PubMed ID: 13677759 [No Abstract] [Full Text] [Related]
4. [Topical administration of an hyperoxygenated fatty acid compound. Preventive and curative effects on pressure ulcer]. Torra i Bou JE; Rueda López J; Segovia Gómez T; Bermejo Martínez M Rev Enferm; 2003 Jan; 26(1):54-61. PubMed ID: 14502907 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of olive oil preparation for topical use in pressure ulcer prevention: Multicentre, controlled, randomised, and double-blinded clinical trial. Díaz-Valenzuela A; García-Fernández FP; Carmona Fernández P; Valle Cañete MJ; Pancorbo-Hidalgo PL Int Wound J; 2019 Dec; 16(6):1314-1322. PubMed ID: 31475465 [TBL] [Abstract][Full Text] [Related]
6. [Last generation hyperoxygenated fatty acids. A product to keep in mind in pressure ulcer prevention]. Nadal MJ; García Rey J Rev Enferm; 2004 Jun; 27(6):74-5. PubMed ID: 15315103 [No Abstract] [Full Text] [Related]
7. [Prevention of pressure ulcers in heels]. Verdú Soriano J; López Casanaova P; Fuentes Pagés G; Torra i Bou JE Rev Enferm; 2004 Sep; 27(9):60-4. PubMed ID: 15526580 [TBL] [Abstract][Full Text] [Related]
8. Topical olive oil is not inferior to hyperoxygenated fatty aids to prevent pressure ulcers in high-risk immobilised patients in home care. Results of a multicentre randomised triple-blind controlled non-inferiority trial. Lupiañez-Perez I; Uttumchandani SK; Morilla-Herrera JC; Martin-Santos FJ; Fernandez-Gallego MC; Navarro-Moya FJ; Lupiañez-Perez Y; Contreras-Fernandez E; Morales-Asencio JM PLoS One; 2015; 10(4):e0122238. PubMed ID: 25886152 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of vascular ulcers and diabetic foot. Non-randomized open clinical evaluation on the effectiveness of "Mepentol Leche"]. Puentes Sánchez J; Pardo González CM; Pardo González MB; Navarro Casado FJ; Puentes Sánchez R; Méndez González JM; González Rojo J; Juárez Morales A; López Fernández IM Rev Enferm; 2006 Oct; 29(10):25-30. PubMed ID: 17144630 [TBL] [Abstract][Full Text] [Related]
11. [Scientific evidence on the new indications for mepentol and mepentol milk]. Nadal Nadal MJ Rev Enferm; 2011 Feb; 34(2):8-13. PubMed ID: 21495381 [No Abstract] [Full Text] [Related]
12. [Skin care and pressure ulcer. Hyperoxygenated fatty acids in the prevention of pressure ulcers and treatment of stage I lesions]. Segovia Gómez T; Bermejo Martínez M; Molina Silva R; Rueda López J; Torra i Bou JE Rev Enferm; 2001 Sep; 24(9):18-22. PubMed ID: 12150123 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of olive oil for the prevention of pressure ulcers caused in immobilized patients within the scope of primary health care: study protocol for a randomized controlled trial. Lupiáñez-Pérez I; Morilla-Herrera JC; Ginel-Mendoza L; Martín-Santos FJ; Navarro-Moya FJ; Sepúlveda-Guerra RP; Vázquez-Cerdeiros R; Cuevas-Fernández-Gallego M; Benítez-Serrano IM; Lupiáñez-Pérez Y; Morales-Asencio JM Trials; 2013 Oct; 14():348. PubMed ID: 24152576 [TBL] [Abstract][Full Text] [Related]
14. Pressure ulcers: effectiveness of risk-assessment tools. A randomised controlled trial (the ULCER trial). Webster J; Coleman K; Mudge A; Marquart L; Gardner G; Stankiewicz M; Kirby J; Vellacott C; Horton-Breshears M; McClymont A BMJ Qual Saf; 2011 Apr; 20(4):297-306. PubMed ID: 21262791 [TBL] [Abstract][Full Text] [Related]
15. A pilot randomised controlled trial comparing reactive air and active alternating pressure mattresses in the prevention and treatment of pressure ulcers among medical ICU patients. Malbrain M; Hendriks B; Wijnands P; Denie D; Jans A; Vanpellicom J; De Keulenaer B J Tissue Viability; 2010 Feb; 19(1):7-15. PubMed ID: 20079647 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of an intensive pressure ulcer prevention protocol in long-term care. Xakellis GC; Frantz RA; Lewis A; Harvey P Adv Wound Care; 1998; 11(1):22-9. PubMed ID: 9729930 [TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers. Arosio E; Ferrari G; Santoro L; Gianese F; Coccheri S; Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):365-72. PubMed ID: 11563899 [TBL] [Abstract][Full Text] [Related]